D50N (p.Asp50Asn) variant of CASQ2 (Calsequestrin-2)

D50N (p.Asp50Asn) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from ClinVar and UniProt describe it as likely benign in the context of Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.26 / 1. The record also includes population frequency data and structural context.

D50N (p.Asp50Asn) variant details